Search - tctmd.com

Displaying 861 - 880 of 1207

Sort: Relevancy | Date

Presentation TCT 2014

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Philippe Gabriel Steg

September 13, 2014

Presentation TCT 2014

HEAT: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Rod H. Stables

September 13, 2014

Presentation TCT 2014

Emerging Funding Models and International Partnerships

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald

September 13, 2014

Presentation TCT 2014

Collaborative Funding Models for De-Risking Investment in Early Stage Technologies

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald, Dale A Wahlstrom

September 13, 2014

Presentation TCT 2014

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Jae-Sik Jang, MD

September 13, 2014

Presentation TCT 2014

The Venture Capital Model: Time to Revisit the Strategy?

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald

September 13, 2014

Presentation TCT 2014

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Daniele Giacoppo, MD

September 13, 2014

Presentation TCT 2014

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Definition, Reliability, and Interpretation of Surrogate Endpoints

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

Subgroup Analyses: Proceed (and Interpret) with Caution

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Eugene H. Blackstone

September 13, 2014

Presentation TCT 2014

First to File: One Year Later

Presenter: James R. Shay

September 13, 2014

Presentation TCT 2014

Randomized vs Observational Studies: Strengths and Weaknesses

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

Reverse Engineering and Region-Specific Innovation

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan

September 13, 2014

Presentation TCT 2014

The Informed Consent Process: More Complicated Than Informed!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Theresa Franklin-Bond

September 13, 2014

Presentation TCT 2014

Organic Innovation: Corporate Perspective

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Jim Barry

September 13, 2014

Presentation TCT 2014

How to Be a Key Enroller in Clinical Trials: Building the Team!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, James C. Blankenship

September 13, 2014

Presentation TCT 2014

Incubators and Accelerators

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Hanson S. Gifford

September 13, 2014

Presentation TCT 2014

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Kate Dalton

September 13, 2014

Presentation TCT 2014

The New MedTech Environment: Changes in the Ecosystem Impacting Technology Development

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan

September 13, 2014

Presentation TCT 2014

Setting-up a Thriving Clinical Research Program: The Basics and More

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, David A. Cox

September 13, 2014

Advertisement

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

HEAT: Core Results and Study Group Interpretation

Emerging Funding Models and International Partnerships

Collaborative Funding Models for De-Risking Investment in Early Stage Technologies

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

The Venture Capital Model: Time to Revisit the Strategy?

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Definition, Reliability, and Interpretation of Surrogate Endpoints

Subgroup Analyses: Proceed (and Interpret) with Caution

First to File: One Year Later

Randomized vs Observational Studies: Strengths and Weaknesses

Reverse Engineering and Region-Specific Innovation

The Informed Consent Process: More Complicated Than Informed!

Organic Innovation: Corporate Perspective

How to Be a Key Enroller in Clinical Trials: Building the Team!

Incubators and Accelerators

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

The New MedTech Environment: Changes in the Ecosystem Impacting Technology Development

Setting-up a Thriving Clinical Research Program: The Basics and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content